Diabetes Vaccine Trial Offers New Hope

Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne. The trial will use insulin administered with a nasal spray to children and young adults who are genetically predisposed to developing Type 1 diabetes.

If successful, researchers believe it could offer thousands of children protection from the disease, and the opportunity to avoid a life of constant blood-sugar monitoring, insulin injections and a regimented diet.

Researchers from the University of Melbourne’s Diabetes Vaccine Development Centre are seeking 13,000 people aged between four and 30 who have a blood relative with Type 1 diabetes – and a higher risk of developing the disease – to undergo screening for the trial.

As part of the four-year program, young people will self-administer the intranasal spray every day for one week, and then once a week for a year, while receiving regular health checks to determine if the onset of diabetes has been delayed or prevented.
A spokeswoman for the National Health and Medical Research Council (NHMRC) said the nasal spray encouraged the body’s protective immune cells to fight the onset of the disease.

===========================

Advertisement
Do you have patients in pain? Over 4,800 Anodyne Therapy Care Providers are increasing circulation and reducing pain for thousands of patients per month. To find out how you can help your patients get back to life, click here.
https://www.diabetesincontrol.com/annodyne/anodyne10_31_01.php